BECKY D LARGENT
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health BLOOMINGTON, IL NPI 1013076702
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health IL Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$1,381.87
- Category: General Payments
- Program years: PY2022–2024
- Record count: 16
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $526.01 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $526.01 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $221.38 | 2 |
| ITI, Inc. | $162.75 | 2 |
| Corium, Inc. | $61.71 | 1 |
| Teva Pharmaceuticals USA, Inc. | $59.97 | 1 |
| Supernus Pharmaceuticals, Inc. | $20.20 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078002914 | Janssen Pharmaceuticals, Inc | $97.51 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078002930 | Janssen Pharmaceuticals, Inc | $123.87 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100220825 | Corium, LLC | $61.71 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143531032 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $47.36 | 06/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143531034 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $115.39 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147876259 | Supernus Pharmaceuticals, Inc. | $20.20 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151574873 | Teva Pharmaceuticals USA, Inc. | $59.97 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.